Delivery Order SPE2DX22D0010-SPE2D826FBA98
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,949.90 to AmerisourceBergen Drug Corp for Zenzedi tablets 20mg on August 13, 2025, with a completion date of August 14, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,272.74 to AmerisourceBergen Drug Corp for Zenzedi 15 mg tablets (30-count supply) with a firm fixed price and ultimate completion date of September 2, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zenzedi tablets 20mg, with a ceiling value of $5,259.00. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is set for ultimate completion by August 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,923.66 on October 29, 2025, for the supply of Zenzedi tablets 15mg under a firm fixed price contract. The award, which is set to be completed by October 30, 2025, was issued by the Medical Supply Chain division of the Defense Logistics Agency without a set-aside designation, indicating the contract was competitively awarded. This delivery order is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zenzedi tablets 30mg, a pharmaceutical product used in attention deficit disorder treatment. This firm fixed-price delivery order, valued at $6.7K, represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the Department of Defense. The $2,645.92 firm fixed-price delivery order contract is for the supply of Zenzedi 20mg tablets, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) for Zenzedi 20 mg tablets valued at $1,636.38 with a firm fixed price contract type. The award was issued on October 15, 2025, with an ultimate completion date of October 16, 2025, and the place of performance is located in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,084.10 delivery order to AmerisourceBergen Drug Corp for 15mg Zenzedi tablets, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and utilizes AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $262 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 15 mg Zenzedi tablets. The firm fixed price order calls for the delivery of 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required from August 23 to August 24, 2023. The Defense Logistics Agency Troop Support Medical establishes contracts to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.44, is a delivery order for the supply of Zenzedi 20 mg tablets. It is a firm fixed-price contract with a performance period ending on May 12, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is the prime contractor, and there is...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBA98Delivery Order
The Department of Defense awarded AmerisourceBergen Drug Corp a delivery order valued at $5,699.16 for Zenzedi tablets (20mg) under a firm fixed-price contract with an ultimate completion date of November 14, 2025. This non-set-aside competitive award supports the Medical Supply Chain, a Defense Logistics Agency component responsible for pharmaceutical procurement across military healthcare systems. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen regularly fulfills competitively awarded delivery orders across multiple therapeutic domains, demonstrating its established capability to meet defense medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 11/13/25 |